コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 over 2000 consecutive patients who underwent parathyroidectomy.
2 patients with pHPT should be considered for parathyroidectomy.
3 athyroid hormone monitoring (IPM) in guiding parathyroidectomy.
4 ities in adults undergoing thyroidectomy and parathyroidectomy.
5 adenoma, increasingly by minimally invasive parathyroidectomy.
6 developed during the evolution of IPM guided parathyroidectomy.
7 for patients with HPT/MEN1/ZES is 3.5-gland parathyroidectomy.
8 n depression, memory and concentration after parathyroidectomy.
9 with primary hyperparathyroidism undergoing parathyroidectomy.
10 004, 254 patients with primary HPT underwent parathyroidectomy.
11 ist physicians in choosing whom to refer for parathyroidectomy.
12 e symptomatic disease should be referred for parathyroidectomy.
13 o 2 groups according to the NIH criteria for parathyroidectomy.
14 s benefited symptomatically after successful parathyroidectomy.
15 g agents, aggressive calcitriol therapy, and parathyroidectomy.
16 c improvement is recognized after successful parathyroidectomy.
17 e of geriatric patients undergoing "limited" parathyroidectomy.
18 s of utmost importance in the conduct of the parathyroidectomy.
19 eated with cinacalcet, vitamin D sterols, or parathyroidectomy.
20 velopment of at least one new indication for parathyroidectomy.
21 renal transplantation and eventually require parathyroidectomy.
22 e assessed preoperatively and managed during parathyroidectomy.
23 uentially applied improved the efficiency of parathyroidectomy.
24 Among patients with pHPT, 6654 underwent parathyroidectomy.
25 = 131 723), 38 983 (29.6%) were treated with parathyroidectomy.
26 a diagnosis, 5280 patients (40.2%) underwent parathyroidectomy.
27 Diagnosis of pHPT and parathyroidectomy.
28 fracture was 10.2% in patients treated with parathyroidectomy.
29 PT did not receive definitive treatment with parathyroidectomy.
30 tify patient characteristics associated with parathyroidectomy.
31 ear-infrared autofluorescence imaging during parathyroidectomy.
32 continued improvement in QOL 10 years after parathyroidectomy.
33 ial for long-term improvement after curative parathyroidectomy.
34 le in guiding a targeted, minimally invasive parathyroidectomy.
35 and patient selection for minimally invasive parathyroidectomy.
36 appropriate, safe, and effective practice of parathyroidectomy.
37 postoperative PTH can guide follow-up after parathyroidectomy.
38 ed to preoperatively plan minimally invasive parathyroidectomy.
39 n the IOPTH half-life of patients undergoing parathyroidectomy.
40 l hyperfunctioning parathyroid glands during parathyroidectomy.
41 istant to pharmacotherapy are candidates for parathyroidectomy.
42 ysfunction that is completely restored after parathyroidectomy.
43 compare those results to patients undergoing parathyroidectomy.
44 vitamin D analogues and sometimes requiring parathyroidectomy.
45 in patients with pHPT who undergo successful parathyroidectomy.
46 l diagnosis of pHPT who underwent first-time parathyroidectomy.
47 eds 95%, but some patients have unsuccessful parathyroidectomies.
48 scular compromise with LSCI was validated in parathyroidectomies.
49 up, 49 patients had subtotal and 3 had total parathyroidectomies.
50 erostin levels significantly increased after parathyroidectomy (0.49 vs. 0.32 ng/ml, P < 0.0001).
51 ological fracture of the pelvis and required parathyroidectomy 1 year after transplant and then manif
54 e, hyperparathyroidism treated with subtotal parathyroidectomy 24 years before, and a slowly growing
55 hip BMD increased transiently in women with parathyroidectomy (4.2% at <2 years) and bisphosphonates
56 parathyroid hormone assay has made "limited" parathyroidectomy a safe, effective treatment option in
58 developing THPT was lower when treated with parathyroidectomy (adjusted hazard ratio, 0.43; 95% conf
60 ng age had a strong inverse association with parathyroidectomy among patients aged 76 to 85 years (un
61 and neurocognitive changes before and after parathyroidectomy and (2) to examine correlations betwee
62 s was 156.8 events per 1000 patients who had parathyroidectomy and 302.5 events per 1000 patients tre
63 fluorocholine PET, 77 subsequently underwent parathyroidectomy and 60 of those had (99m)Tc-sestamibi
64 rs was 20.4 events per 1000 patients who had parathyroidectomy and 85.5 events per 1000 patients trea
65 al neck dissection (CND) combined with total parathyroidectomy and autotransplantation of parathyroid
66 shown to be accurate as an adjunct to guide parathyroidectomy and has changed the operative manageme
67 uss the advantages and drawbacks of targeted parathyroidectomy and the performance of various scintig
70 n its ability to orient a targeted (focused) parathyroidectomy and to recognize ectopic locations or
71 ngry bone syndrome) is well-recognized after parathyroidectomy and usually resolves after a few weeks
72 ed, image-guided surgery (minimally invasive parathyroidectomy) and bilateral exploration are appropr
73 SHPT while on dialysis, 228 (4.5%) underwent parathyroidectomy, and 4866 (95.5%) received cinacalcet.
74 he study, 61 patients (50 percent) underwent parathyroidectomy, and 60 patients were followed without
75 yroidectomy, transurethral prostate surgery, parathyroidectomy, and carpal tunnel) and major surgical
81 red to meet consensus guideline criteria for parathyroidectomy based on diagnosis codes indicating os
82 other diseases are often denied referral for parathyroidectomy because of the associated risks of gen
83 images of parathyroid glands obtained during parathyroidectomies between November 18, 2019, and Decem
84 In some instances, NCHPT may be treated with parathyroidectomy, but the indications and long-term out
85 e suitable for medical follow-up rather than parathyroidectomy, but there are no long-term randomised
86 ients (median age 63, F/M=3.6) had a focused parathyroidectomy by open (88.7%) or endoscopic approach
87 observed in the surgery group suggests that parathyroidectomy can improve functional capacity, and h
88 d data for 17 494 participants who underwent parathyroidectomies conducted across 125 hospital trusts
89 ormed to assess the long-term association of parathyroidectomy, defined as a minimum of 1-year postop
92 ts were adults (age >=18 years) referred for parathyroidectomy due to primary hyperparathyroidism.
93 l anesthesia) or extended minimally invasive parathyroidectomy (ex-MIP; locoregional anesthesia, cons
97 ps of similar patients underwent reoperative parathyroidectomy for failed surgery or recurrent diseas
98 Approximately 1-4% of patients undergoing parathyroidectomy for HPT are normocalcemic before surge
100 e of 1235 consecutive patients who underwent parathyroidectomy for PHPT at our institution between Ma
101 2009 to 2018 for all patients who underwent parathyroidectomy for pHPT between January 2011 to Decem
103 k and mediastinum of 102 patients undergoing parathyroidectomy for pHPT were preoperatively evaluated
108 t of patients (95%) with ePTH after curative parathyroidectomy for primary HPT will not develop recur
109 pective study of patients undergoing initial parathyroidectomy for primary hyperparathyroidism (2002-
110 Focused unilateral or minimally invasive parathyroidectomy for primary hyperparathyroidism (pHPT)
112 period, 202 consecutive patients undergoing parathyroidectomy for primary hyperparathyroidism at a t
113 eating adult patients who underwent elective parathyroidectomy for primary hyperparathyroidism betwee
114 enter of 100 consecutive patients undergoing parathyroidectomy for primary hyperparathyroidism due to
115 total of 797 consecutive patients underwent parathyroidectomy for primary hyperparathyroidism with i
117 adults (age 18 y) treated with cinacalcet or parathyroidectomy for SHPT before receiving KT between 2
120 complete excision of abnormal glands during parathyroidectomy for sporadic primary hyperparathyroidi
121 nue to be applied to all patients undergoing parathyroidectomy for sporadic primary hyperparathyroidi
124 investigate long-term outcomes after focused parathyroidectomy (FPTX) and open 4-gland parathyroid ex
125 inacalcet group and 15 of 15 patients in the parathyroidectomy group (P=0.04) achieved normocalcemia.
127 l neck exploration (BNE, n = 396) or limited parathyroidectomy guided by parathormone dynamics (LPX,
129 erparathyroidism were treated with "limited" parathyroidectomy guided by preoperative localization an
130 treated with cinacalcet, those treated with parathyroidectomy had a lower risk of developing THPT (a
133 ary hyperparathyroidism (pHPT) with curative parathyroidectomy has been shown to improve nonspecific
139 ssociated with outpatient minimally invasive parathyroidectomy have shifted the patterns of recommend
140 or hyperparathyroidism, parathyroid hormone, parathyroidectomy, hypercalcemia, and quality of life.
141 ssue Diagnosis, Nodal Dissection, Concurrent Parathyroidectomy, Hyperthyroid Conditions, Goiter, Adju
142 ssue Diagnosis, Nodal Dissection, Concurrent Parathyroidectomy, Hyperthyroid Conditions, Goiter, Adju
144 Complications following thyroidectomy and parathyroidectomy in children can have profound, life-lo
145 n D supplementation has reduced the need for parathyroidectomy in dialysis patients with secondary hy
148 to allow confident performance of unilateral parathyroidectomy in patients with sporadic primary hype
149 dical modalities will need to be compared to parathyroidectomy in randomized controlled clinical tria
150 ant score improvement in long-term QOL after parathyroidectomy, including 1 study that showed continu
159 andomized study to evaluate whether subtotal parathyroidectomy is more effective than cinacalcet for
165 econstruction, parotidectomy, thyroidectomy, parathyroidectomy, laryngectomy, or transoral robotic re
169 es in patients undergoing minimally invasive parathyroidectomy (MIP) due to primary hyperparathyroidi
170 The value of IPM during minimally invasive parathyroidectomy (MIP) has been questioned, particularl
176 l anesthesia (n = 107) or minimally invasive parathyroidectomy (n = 23) employing cervical block anes
178 adult patients who underwent thyroidectomy, parathyroidectomy, neck dissections for thyroid malignan
181 areer, but does not reach the thresholds for parathyroidectomies or adrenalectomies until after 4 yea
183 primary hyperparathyroidism is managed with parathyroidectomy or observation with monitoring, while
184 39-1.47]); stage 3 CKD decreased the odds of parathyroidectomy (OR, 0.71 [95% CI, 0.68-0.74]); and os
185 gastrectomy (OR, 2.56 [95% CI, 1.89-3.48]), parathyroidectomy (OR, 1.24 [95% CI, 1.14-1.34]), and to
186 ory of nephrolithiasis increased the odds of parathyroidectomy (OR, 1.43 [95% CI, 1.39-1.47]); stage
187 andomly assigned to either a surgical group (parathyroidectomy) or a control group (observed for 6 mo
188 ces were found in operative time, accidental parathyroidectomy, parathyroid autotransplantation, or w
194 F/35 M) with ZES/MEN1/HPT underwent initial parathyroidectomy (PTX) and were followed at 1- to 3-yea
199 f rats were studied: untreated CRF, CRF with parathyroidectomy (PTX), CRF with the calcium channel bl
202 changed dramatically, it is unknown whether parathyroidectomy rates continue to decline in the Unite
210 roidism is still poorly understood, surgical parathyroidectomy results in long-term cure in greater t
211 n patients with primary hyperparathyroidism, parathyroidectomy results in the normalization of bioche
215 h autotransplantation (TPTX+AT) and subtotal parathyroidectomy (SPTX) are the standard surgical proce
216 The time course of bone biomarkers after parathyroidectomy suggests that bone resorption normaliz
218 -fluorocholine PET in patients who underwent parathyroidectomy, the CLR based on the masked reader co
220 23 renal transplant recipients referred for parathyroidectomy to define the impact of renal transpla
221 to surgical care and develop tools to target parathyroidectomy to older adults most likely to benefit
223 ere censored at the time of cointerventions (parathyroidectomy, transplant, or provision of commercia
224 were female and had low comorbidity; 78% had parathyroidectomy under ambulatory, minimally invasive t
225 imary hyperparathyroidism were imaged before parathyroidectomy using (18)F-fluorocholine PET/MRI.
228 constructed to determine the association of parathyroidectomy vs nonoperative management with incide
229 We evaluated that an annual caseload of 31 parathyroidectomies was the best threshold to discrimina
234 Mean time from renal transplantation to parathyroidectomy was 997 +/- 184 days, with a mean preo
235 ine-Gray competing risk regression confirmed parathyroidectomy was associated with a lower probabilit
236 This longitudinal cohort study found that parathyroidectomy was associated with a lower risk of an
237 those who underwent nonsurgical management, parathyroidectomy was associated with a reduced risk of
243 analyses stratified by baseline BMD status, parathyroidectomy was associated with reduced fracture r
250 nsensus conference criteria for undergoing a parathyroidectomy were randomly assigned to either a sur
251 nty-one patients undergoing thyroidectomy or parathyroidectomy were recruited to compare LSCI and ICG
252 decrease in oxygenation was assessed during parathyroidectomies when the blood supply to the PTG was
254 patients undergoing more difficult secondary parathyroidectomy with and without the adjunctive suppor
255 hypocalcemia occurs after subtotal or total parathyroidectomy with auto transplantation as well as a
257 preventive total thyroidectomy routine total parathyroidectomy with autotransplantation and CND gives
261 t a high-volume tertiary referral center for parathyroidectomy with blinded examiners and a 6-month f
263 ignificant differences in the association of parathyroidectomy with fracture risk by age group, sex,
267 White individuals), 63 136 (30.0%) underwent parathyroidectomy within 1 year of diagnosis, and 147 07